Skip to content
Sunday, June 29, 2025
Latest:
  • A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
  • Baylor recognizes faculty excellence in research with DeBakey Awards
  • What you need to know about sickle cell disease
  • From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
  • Researchers uncover rare gene variants contributing to systemic sclerosis risk
Baylor College of Medicine Blog Network

  • Home
  • Momentum
    • About Momentum
    • Resources
    • Contributors
      • Taylor Barnes
      • Dana Benson
      • Molly Chiu
      • Julie Garcia
      • Graciela Gutierrez
      • Anna Kiappes
      • Andy Phifer
      • Homa Shalchi
      • Melissa Tucker
    • Contact Us
  • From The Labs
    • About From the Labs
    • Follow From The Labs on Twitter
  • Policywise
    • About PolicyWise
    • Follow @BCMEthics on Twitter
  • The Stitch
    • About The Stitch
  • Progress Notes
    • About Progress Notes
    • Progress Notes Editors
    • Connect With Us
  • bcm.edu

Mpro

From The Labs

Innovative, faster and more cost-effective technology identifies drug that inhibits SARS-CoV-2 growth in the lab

August 31, 2021 COVID-19,  COVID-19 drugs,  DNA-Encoded Chemistry Technology.,  drug discovery,  Mpro,  Research,  SARS-CoV-2

Baylor College of Medicine researchers are contributing to the development of antiviral drugs to treat people with COVID-19.

Read More

From the Labs: Image of the Month

Blood vessels (magenta) intertwined with metastatic medulloblastoma tumor cells (green) nestled within the protective layers that surround the mouse spinal cord. From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

https://www.youtube.com/watch?v=SlNiMWHUhbc

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951